Search This Blog

Saturday, 25 April 2026

Surgery - Cut and pasted because they don't have a share button for blogs. Also on my facebook and linkedin page

 When something goes wrong on a plane, investigators turn to the black box. Now, a similar tool is being tested in operating rooms – where researchers review synchronized video, audio and physiological data to gain a better understanding of what happens during surgery.  

Patricia Trbovich, an associate professor at the Institute of Health Policy, Management and Evaluation at the Dalla Lana School of Public Health, is using this “OR black box” not just to analyze failures, but to study what goes right. Her research shows that outcomes often hinge on small, overlooked details – how a surgical team communicates, where equipment is placed or how an operating room is laid out. 

The system captures video and audio from the operating room, patient vital signs and even the heart rates – and heart-rate variability – of clinicians, recorded through wearable devices. Originally developed by Dr. Teodor Grantcharov to improve surgical training and patient safety, the OR black box now allows researchers like Trbovich to examine how subtle factors – from team dynamics to the space around the operating table – influence how an operation unfolds. 

More than two million surgeries are performed in Canada each year. Yet national data doesn’t fully capture the challenges in operating rooms. Researchers have noted that surgical patients account for the highest rates of safety incidents among hospitalized patients, but many priorities identified by health-care experts – including outcomes that matter most to patients – are not well captured in existing data. 

That’s where black box research can help. By reviewing 195 surgeries across hospitals in Toronto and Palo Alto, California, Trbovich and her colleagues are identifying patterns that traditional reporting systems overlook. She emphasizes: poor surgical outcomes are not necessarily due to failure by clinicians. They are often rooted in system design.

“Our black box data reveals again and again that it’s not a lack of skill,” she says, “but rather a lack of design leading to most of the errors we see. I notice practitioners’ resilience – their ability to make small adjustments when the unexpected happens – much more than practitioner error.” 

    A detail of an operating-room illustration shows a surgical checklist on the entrance door, labeled 1.
    Professor Patricia Trbovich worked with hospitals to condense their surgical checklists (1) and improve their visibility in the operating room. All illustrations by Chris Philpott
    A detail of an operating-room illustration shows a ceiling-mounted microphone labeled 2 and ceiling-mounted camera, labeled 3.
    Microphones (2) capture operating room audio while cameras (3) record the procedure.
    A detail of an operating-room illustration shows a clinician wearing a device that tracks heart rate, indicated by label 4.
    Wearables (4) track clinicians’ heart rates – and stress levels – during surgery.
    A detail of an operating-room illustration shows a surgical team around a patient, with label 5 marking names on surgical caps for clearer communication and label 6 a “black box” system that records data during surgery.
    Names on surgical caps (5) promote clearer communication, less hierarchy. Combined data, gathered by the black box (6), reveal how subtle factors affect surgical outcomes.

    HUMAN FACTORS 

    Rather than focusing solely on human mistakes, Trbovich asks broader questions: How was the operating room designed? Was someone interrupted at a critical moment? Was the equipment where it should have been? This approach – known as human factors – examines how people interact with their environment. 

    Trbovich, the Badeau Family Research Chair in Patient Safety and Quality Improvement at North York General Hospital, has identified distractions, unclear communications and missing or poorly designed equipment as key safety concerns. Different members of the surgical team need to focus at different points in a procedure, she says. When colleagues understand those moments, they can avoid unnecessary disruptions and protect each other’s concentration.

    Just as important are the often invisible adjustments teams make to prevent problems from escalating. A lead surgeon may switch roles with a surgical trainee. A nurse may anticipate the need for an extra instrument. The team may call in an expert to advise. These actions rarely appear in incident reports, but they are essential to keep patients safe. “Success often leaves no trace,” Trbovich says. “We’re trying to make those invisible moments visible.”

    CHANGING OUTCOMES  

    As Trbovich’s team studies OR black box data, they are developing ideas for operating room improvements. Some fixes are straightforward. For instance, hospitals often add items to the World Health Organization’s surgical safety checklist. Over time, some checklists become so long and densely printed that they are difficult to read from the operating table. Trbovich worked with hospitals to condense their lists and improve their visibility. 

    Her team is also studying how to strengthen psychological safety in operating rooms. Rather than focusing only on individual behaviour, they are testing cultural changes such as adding names to surgical caps, offering opportunities for confidential feedback and creating structured pauses during surgery for team input – small adjustments that make speaking up easier and more routine.

    Looking ahead, Trbovich is leading a project to develop predictive tools that could flag safety threats as surgeries proceed. The goal is to use AI to analyze black box data and provide timely alerts to clinical teams. The system is being designed with clinicians to ensure it augments – rather than replaces – human judgment. It is also being tested to minimize unnecessary warnings and avoid “alert fatigue,” says Trbovich.

    Whether the solution involves redesigning a checklist or developing AI-driven insights, the principle is the same: better systems support better care. Trbovich compares it to Formula 1 racing. “F1 drivers aren’t superhuman,” she says. “They’re fast because every part of the system – the car, the track, the data – is engineered around performance.” Likewise, in the operating room, success depends on more than individual expertise. It depends on an environment designed to help skilled teams do their best work – even when the unexpected happens.


      Daniel Drucker’s path to a discovery that would transform millions of lives began not with a breakthrough – but a setback. (cut and pasted for you.


      It was 1984. Newly arrived at Harvard Medical School for a research fellowship, Drucker planned to study thyroid disease – an interest he had developed as a University of Toronto medical student and later as a resident at Toronto General Hospital.

      Instead, his supervisor, Joel Habener, delivered unexpected news: the lab was phasing out its thyroid program. Drucker would be studying glucagon, a hormone that regulates blood sugar.

      “I was very clear I was going to be a thyroid clinician,” recalls Drucker – now a senior investigator at the Lunenfeld-Tanenbaum Research Institute at Sinai Health and a University Professor of medicine in U of T’s Temerty Faculty of Medicine. “The fact that I ended up working on these peptide hormones that had nothing to do with the thyroid was disappointing.”

      Yet the change proved pivotal.

      Within years, Drucker would help identify and characterize glucagon-like peptide-1 (GLP-1) – a hormone produced in the gut that stimulates insulin release and curbs appetite. This work laid the scientific foundation for blockbuster drugs such as Ozempic, approved for treating type 2 diabetes (and widely used for weight loss), and Wegovy, approved for weight loss.

      The medications have rapidly become household names – generating headlines, social media buzz and fodder for talk show hosts.

      Less widely discussed is the growing evidence that GLP-1-based therapies may help treat a wide array of other conditions, from kidney disease to neurological disorders.

      These advances have earned Drucker a growing list of honours, including the Canada Gairdner International Award and recognition on Time magazine’s list of the world’s 100 most influential people. Last year, Drucker, Habener and three international collaborators received the Breakthrough Prize in Life Sciences – often described as the “Oscars of Science” for “the discovery and characterization of GLP-1 and revealing its physiology and potential in treating diabetes and obesity.”

      For Drucker, however, the most meaningful reward is seeing how his fundamental research, driven by curiosity, has resulted in game-changing treatments that are now helping millions of people.

      “Nobody set out in the GLP-1 field 25 or 30 years ago to invent a drug that produced weight loss or would reduce heart disease, liver disease or kidney disease,” says Drucker, who holds the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology. “This all came about from basic science observations that were unexpected but thankfully translated into clinical findings of use for patients with these challenging disorders.”

      Medical researcher Daniel Drucker faces the camera and looks to the side, with a neutral expression
      Daniel Drucker. Photo by Ian Patterson

      A HORMONE WITH PROMISE

      The breakthroughs did not come quickly. It took decades of painstaking work for Drucker’s early laboratory findings to evolve into widely used treatments.

      In 1987, he returned to U of T as an assistant professor at the Banting and Best Diabetes Centre. By this time, Drucker had become the first to identify the biologically active form of GLP-1 and to show, in insulin-producing cells grown in a dish, that GLP-1 boosts insulin secretion when glucose levels are high – but not when they’re low.

      Yet GLP-1 had a major drawback: it degraded rapidly in the human body. Any therapy based directly on the hormone would be short-lived.

      The solution came from an unlikely source – the Gila monster, a desert reptile whose venom contains a hormone that stimulates insulin release but is more stable than human GLP-1.

      With help from the Royal Ontario Museum, Drucker obtained a Gila monster and analyzed its venom. He discovered that the reptile’s hormone could activate the human GLP-1 receptor, even though it was structurally distinct from the human body’s own GLP-1. His lab published the findings in 1997, helping to set the stage for drug development.

      Years of further research and industry collaboration followed. In 2005, a synthetic version of the reptilian hormone became the first GLP-1 drug approved for type 2 diabetes, administered by a twice-daily injection. (Today’s medications offer longer-lasting, once-weekly dosing).

      By then, Drucker’s lab had also helped establish that GLP-1 acted on receptors in the brain to suppress appetite, making these receptors a viable target for obesity treatment. (Prior research by other scientists had shown GLP-1 also curbed appetite by slowing gastric emptying.) This led to the approval of the first GLP-1 drug for weight loss in 2014.

      TREATING CHRONIC CONDITIONS

      With GLP-1 weight-loss drugs now surging in popularity, Drucker says he is concerned about how celebrity culture and social media hype could affect public perception and usage. At the same time, he hopes growing awareness of their effectiveness can help combat the stigma that obesity stems from a lack of discipline.

      “People have struggled for years despite doing everything we tell them: the traditional advice of eat less and move more is just not helpful for many. Now, we see spectacular improvements in their health,” says Drucker. “It’s tremendously satisfying, and it allows many of these individuals to turn to the doubters in society and say, ‘I just needed help – and the GLP-1 medicines were the help that I needed.’”

      Meanwhile, clinical evidence continues to expand. GLP-1 drugs are now used to reduce cardiovascular risk, kidney disease, metabolic liver disease and sleep apnea – owing to their effects on metabolism, inflammation and insulin sensitivity.

      The hormone is also produced in the brain, says Drucker, where it appears to have protective properties. Clinical trials are underway to evaluate GLP-1 drugs for neurodegenerative diseases. Researchers have observed that they can dampen reward-seeking behaviour, raising the possibility that the drugs could one day play a role in treating substance use disorders.

      As the list of potential benefits of GLP-1 grows, Drucker warns that the buzz must be balanced with caution and scientific rigour.

      “There’s a tendency to say GLP-1 is a wonder drug, but it’s not going to help all of these disorders. We have to prepare to be disappointed,” he says. “But we’re very lucky that there are so many clinical trials underway that will tell us when GLP-1 is useful and when it’s not. It’s going to be an exciting next couple of years.”

      Drucker’s current research extends beyond GLP-1. His lab has also discovered the role of a related hormone, GLP-2, in stimulating intestinal growth – work that led to a breakthrough treatment for short bowel syndrome, a rare and debilitating condition in which patients can’t absorb sufficient nutrients due to missing or damaged intestine.

      Today, his focus remains on understanding how GLP-1 improves brain health and reduces inflammation across a range of diseases, while mentoring the next generation of researchers who will push the field forward.

      He credits U of T’s research ecosystem as central to that work.

      “I have experts in almost every endeavour working across the street from me at U of T and hospital research institutes,” he says. “It’s an extremely rich environment full of scientific talent, with people who are friendly and approachable and can elevate what we do.

      “That’s why I’ve never left. I don’t think I could do what I do easily in other places. This has been a fantastic scientific home for me.”

        Leave a Reply

        Your email address will not be published. Required fields are marked *

        1. Smita Kothari says:


        Thursday, 23 April 2026

        More about Suicide notes also a bit of Indie Conference - connecting

         

        Notes:

             Labelling Emotions:   I am not bad, I feel the sadness - describe the sadness-describe the feeling - emptiness.  Why should I have fun if they can’t anymore.  They are quite fatigued - feel their soul and recharge.   Clients hold so much shame.  “I can’t do this - too sad.”  Then say in a gentle way, “You’re choosing this and you can choose.  This can take you from  a deeper depression and will move in small steps.  “You have choices.”  Show them they do have the problem to change.

             “You too are precious and deserving.”  I am worthy of a good life.  I am worthy of happiness.  Is this behaviour and will it enforce you’re choosing to stay in depression?

             “Let’s look at the achievements in your life.”  “Think about that on your cruise.”

        “Let’s look at your life and how you came out?”


        When the storm hits:  Can’t stand the pain.  Ice water to splash on face, intense exercise, paced, breathing.


        Five senses:  hear, see, touch, smell, taste.  Distractive, activities, moves.  Contributing:  Do something kind for another person.  Movement.  How would you sit if you were confident? 

        Emotional states can be influenced by a movement.


        Letter writing,  Guided Imagery, Empty chair, Legacy books.

        Aunt had committed suicide.  Thought of once together.  Aunt said thanksgiving.  What was it like a year later?  Mother was working in the kitchen and screamed, “I miss my sister.”  This is a woman who tried to commit suicide.  “Imagine visiting you at the cemetery. 


        scenario two:   Going through a troubled time.  Now pick up the phone and ask, “How did you go through it?”  


        Continuing with Imagery helps………


             Before going to the Conference I had received an email indicating that I could get a review of the first one or two pages of my next book.  How can I resist?  I like my own publisher/editor but I did want the freebie.  She wanted to know about the next book and believe it or not I am quite reserved about telling too much until I have at least mailed a copy to myself by registered mail.  Two pages wouldn't hurt.  I thought she would check grammar structure etc....However, she was focused on two things - two of my characters, one being that I was perhaps stereo typing and the other the focus on my imaginary client.  She felt it was too heavy.  Well, you have been reading my notes for quite some time.   I have attended many lectures, conference and with two degrees with a focus on psychology plus post grad well,  I can assure you it is heavy.  Thus I do use a character to lighten it.  I feel comfortable doing so because I like my character.  In my life I have seen so many people and do not hesitate to blend any in my characters.  I do not write to appease anyone particular person I may be offending.  I write fiction.  It is my story.  It is my character.  I kill people (in my books only people).  Listening to the Editor I thought that it should take priority over personality.  So, I thought of perhaps teaching at an University in my book to explain to students what is happening in a therapy room something similar to my notes.  But I probably won't.  My story is about a therapist because my readers have consistently asked if I write about therapy.  They seemed disappointed.   I could not before because then it would have been too much.  I was more comfortable killing people.  Now, I can take the leap and join the two interests.  The Editor wanted me to talk more about the client.  I will not.  It is my story and the main focus is killing people and not clients.  Clients in the book are meant to educate a bit about problems that people in general experience and some things are horrific.  It is not meant to be the focus.  I am not saying they will not be killed.  Good talk.  Have a good weekend.  


        Tuesday, 21 April 2026

        Writers Corner - Toronto Indie Author Conference - I attended for the entire weekend and recommend it for Authors


              It was long and tiring but I loved it all.  I did recommend that next time it would be nice to have an overnighter to relax and lounge and network more.  I learned a lot and now I will have the time to research and implement what is best for me and my readers.  At one point someone sitting next to me who sells a lot of books (galore) talked about her superfans amount and I mentioned I have about two.  She got up shortly afterwards and disappeared.  I found that so funny.  The next funny thing that happened was that I was looking at a guy wearing a base ball cap and I couldn't figure out what the cartoon character on it was.  He turned to see me looking so I told him I was looking at the emblem on the cap and walked away.  I heard him say,  "Next time look at me."   I turned around asnd said, "excuse me?"     To which he replied it was a Raptor's emblem.  I believe that is a baseball team, rather famous in Toronto.  I guess you all know by now that sports is not my forte.  Anyhow,  I have only been accepting cash at book fairs and therefore I have been losing a lot of money because people (I am actually one of them) don't usually use cash.  Now, keep in mind that I give out receipts.  I also don't normally bundle my books so I will do that.  So, now I am exploring what my best option is.  Most are using square, which is probably where I am headed.  Now,  I do have many people who read my blogs so I want to make it easier for all to buy my ebooks.  So, I have an option of KOBO which I think I have one ebook on and Dreamscape.  Now KOBO is Canadian and Dreamscape is from the States.  The two I met were from Ohio and I have driven past there when driving to Disney World.  Now they have a contract which I am concerned about but I will like to see it,  determine where in the world they sell.  They have ebooks in the USA library and Canadian.  I have quite a few Americans who have been reading my blogs since I started so I want them to have access to my books.  I will get money from there and Canada.  I don't think KOBO will put it in American libraries so I sent both representatives an email and will go from there.  I am concerned about the contract if it limits me and therefore will probably go to KOBO because I have no restrictions.  One of the things I learned that when selling ebooks it has to be the same price from where ever I am selling, so I shall have to ensure I do that.  If you ever see different prices please let me know so I can rectify that.  So this is what I am at right now.  I am on shopify now (silvaredigonda.shopify.com) and thought that everyone could get my books/ebooks from there but I was wrong.  I received notification that they will be updating to more countries but there is mega sheets of contract.  What stood out was "not responsible" and "crypto".  I didn't read it all because there was endless scrolling and when it comes to contracts I want to know exactly what is involved so it appears I will be looking at getting off shopify.   Shopify is a Canadian Company but charges in American dollars which I do not like.  I am with godaddy, an American Company which I pay for once a year in Canadian funds.  I used them for psychotherapy and don't need the account anymore.   I could switch to them for books but have to explore my options more.  So, you see I have to stop writing for a while to get this all sorted.  I shall keep you up to date.  There is a lot more to say, so you will be hearing more.  Have a nice day!  Wish me luck!  As soon as I get on a new or different platform, I shall let you know immediately.  Good talk.

        Thursday, 16 April 2026

        Another segment about Suicide. notes.


        When Child Dies by suicide or accident, pain does not fully heal (as told by parents)


        Victim is also the perpetrator - miss you and angry with you.

        An individual set himself on fire in his backyard.  His parents witnessed it as well as his children.  Emotions - anger - to love - to anger - to love.  This person is the victim of the event and perpetrator and that is the difference.  There is guilt, shame, helplessness.  Shame - what does it say about me?  How do I deal with you not in my life.  How do I counsel the children?  Was I an inadequate in life?  

        Do they talk about it?  No and that is why therapy is required.  Explore that guilt.  If I can blame myself, I’m not powerless.  We look for reasons and sometimes blame counsellors.  Suicide is a choice made by the individual and usually thought about for a long time, usually leading to distorted thoughts.  Usually, a therapist will ask - Why didn’t they tell me?  A PHD therapist stated, “I would have stopped him.”  She had suffered for about a year wondering why.  If an individual knows you will stop him, he loses his choice.  Some therapist will leave the profession.  There is a limit anyone can do to prevent suicide.  If I interpret and stop you to prevent suicide -  a heavy burden if I think I could have stopped this and didn’t.  One person saw a psychiatrist, a social worker and a therapist all in two weeks and committed suicide.  How does it affect others?  Maybe I should join them?  As a clinician you can teach to cope, but you cannot do it alone.  Give permission and self care (recharging batteries).  Address guilt and shame.  Teach to identify and name emotions.  Name it and take it.  1 to 10, How sad do you feel?  If they say 10, try to bring it down to 5.  Teach mindfulness, to increase non-judgemental self - awareness.  This can help clients catch it early before they go into crises.  Cognitive Behaviour Therapy - Identify situations/thoughts that trigger me and may increase my feelings of sadness and or despair.  Address guilt/shame.   


        To be continued.  Have a good weekend.







         

        Tuesday, 14 April 2026

        silvaredigonda.myshopify.com

              



        Have you read my book?  What are you waiting for?  You will find it on print and e-format.
        Any problems - let me know.  Feel free to tell me what you think of it.  I am surprisingly asked at fairs if my books are any good.  Since, I am no long stunned by the question,  I have decided on a fair answer.   Thank you for asking such a good question.  I have written the worse book I could think of.  Please let me know if it has met your standard.